Europe • Euronext Paris • EPA:ALINS • FR0011179886
The current stock price of ALINS.PA is 0.264 EUR. In the past month the price increased by 16.3%. In the past year, price increased by 1.15%.
ChartMill assigns a technical rating of 4 / 10 to ALINS.PA. When comparing the yearly performance of all stocks, ALINS.PA turns out to be only a medium performer in the overall market: it outperformed 48.46% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to ALINS.PA. Both the profitability and financial health of ALINS.PA have multiple concerns.
Over the last trailing twelve months ALINS.PA reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by -56.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -70.48% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed ALINS.PA and the average price target is 0.24 EUR. This implies a price decrease of -7.27% is expected in the next year compared to the current price of 0.264.
For the next year, analysts expect an EPS growth of 37.5% and a revenue growth 71.49% for ALINS.PA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EQS | EQUASENS | 12.72 | 585.562M | ||
| GPI | GPI SPA | 16.24 | 467.764M | ||
| ALCGM | CEGEDIM SA | 7.61 | 179.07M | ||
| ALMDT | MEDIAN TECHNOLOGIES | N/A | 157.162M | ||
| AGFB | AGFA-GEVAERT NV | 9.31 | 73.54M | ||
| AJ91 | DOCCHECK AG | N/A | 64.896M | ||
| M3V | MEVIS MEDICAL SOLUTIONS AG | N/A | 44.044M | ||
| MLLAB | MEDIA LAB SPA | N/A |
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie and currently employs 76 full-time employees. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.
INTRASENSE SAS
1231 Avenue du Mondial 98
Montpellier OCCITANIE FR
Employees: 76
Phone: 33467130130
Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie and currently employs 76 full-time employees. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.
The current stock price of ALINS.PA is 0.264 EUR. The price decreased by -2.22% in the last trading session.
ALINS.PA does not pay a dividend.
ALINS.PA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
ALINS.PA stock is listed on the Euronext Paris exchange.
INTRASENSE SAS (ALINS.PA) has a market capitalization of 13.92M EUR. This makes ALINS.PA a Nano Cap stock.